E
ZyVersa Therapeutics, Inc. ZVSA
$0.1221 -$0.0079-6.08% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 19.99% 20.16% 89.34% 17.27% 96.48%
Total Depreciation and Amortization -- -- 93.13% -98.57% 0.00%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 10.33% -50.45% -97.65% 7.64% -99.77%
Change in Net Operating Assets -25.88% 126.21% 94.41% -6.10% -77.50%
Cash from Operations 20.50% 53.08% 56.07% 31.18% -369.60%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -25.17% -39.19% -73.00% -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 37.58% 67.25% --
Cash from Financing -- -30.68% -39.43% -71.67% 100.00%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 19.58% 107.30% -9.69% -99.75% -82.40%